middle.news
Lumos Clinches Full Medicare Reimbursement for FebriDx Across All US Regions
1:31pm on Friday 21st of November, 2025 AEDT
•
Healthcare
Read Story
Lumos Clinches Full Medicare Reimbursement for FebriDx Across All US Regions
1:31pm on Friday 21st of November, 2025 AEDT
Key Points
Complete Medicare reimbursement coverage secured for FebriDx at US$41.38 per test
National Government Services (NGS) finalizes coverage, covering key Midwestern and Northeastern states
All seven Medicare Administrative Contractors now recognize FebriDx under Clinical Lab Fee Schedule
Next focus on formalizing written policies to streamline reimbursement claims
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Lumos Diagnostics Holdings (ASX:LDX)
OPEN ARTICLE